The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 09, 2017
Filed:
Dec. 06, 2013
Applicant:
Kbp Biosciences Co., Ltd., Jinan, Shandong Province, CN;
Inventors:
Assignee:
KBP BioSciences Co., Ltd., Jinan, Shandong Province, CN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 209/14 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 403/12 (2006.01); A61K 31/4045 (2006.01); A61K 31/407 (2006.01); A61K 31/496 (2006.01); C07D 405/14 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 417/14 (2006.01); C07D 209/34 (2006.01); A61K 45/06 (2006.01); A61K 31/5377 (2006.01); C07D 409/14 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); C07D 209/30 (2006.01); C07D 401/14 (2006.01); A61K 31/435 (2006.01); A61K 31/438 (2006.01); A61K 31/439 (2006.01); A61K 31/4439 (2006.01); A61K 31/4995 (2006.01); A61K 31/506 (2006.01); C07D 403/14 (2006.01); C07D 471/10 (2006.01); C07D 471/14 (2006.01); C07D 487/08 (2006.01); C07D 487/10 (2006.01); C07D 491/107 (2006.01); A61K 31/4155 (2006.01); A61K 31/4196 (2006.01); A61K 31/433 (2006.01); A61K 31/454 (2006.01); A61K 31/5383 (2006.01); C07D 471/04 (2006.01); C07D 405/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 31/4045 (2013.01); A61K 31/4155 (2013.01); A61K 31/4196 (2013.01); A61K 31/433 (2013.01); A61K 31/435 (2013.01); A61K 31/438 (2013.01); A61K 31/439 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/4995 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 31/5383 (2013.01); A61K 45/06 (2013.01); C07D 209/30 (2013.01); C07D 209/34 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 471/10 (2013.01); C07D 471/14 (2013.01); C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 487/10 (2013.01); C07D 491/107 (2013.01); C07D 498/04 (2013.01);
Abstract
The present invention relates to a compound represented by general formula (I), a method for preparing said compound, a pharmaceutical formulation containing said compound, and the use of said compound in manufacture of a medicament for treating or preventing the fibrous degeneration disease and treating the excessive proliferation disease: wherein ring A, X, R, R, R, R, R, R, R, R, R, a, b and n are defined as those in the description.